Published On: Wed, Oct 19th, 2016

Merck KGaA (MKGAY) Latest Broker Views


A number of investment brokers have recently updated their price targets on shares of Merck KGaA (MKGAY).

Most recent broker ratings

10/13/2016 – Merck KGaA was upgraded to “buy” by analysts at Bank of America Merrill Lynch.

08/19/2016 – Merck KGaA had its “buy” rating reiterated by analysts at UBS. They now have a USD 70 price target on the stock.

08/12/2016 – Merck KGaA had its “hold” rating reiterated by analysts at Berenberg Bank.

08/08/2016 – Merck KGaA was upgraded to “outperform” by analysts at Credit Suisse. They now have a USD 73 price target on the stock.

08/08/2016 – Merck KGaA had its “hold” rating reiterated by analysts at Jefferies. They now have a USD 57 price target on the stock.

02/04/2016 – Merck KGaA had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 56 price target on the stock.

01/29/2016 – Merck KGaA had its “outperform” rating reiterated by analysts at BMO Capital Markets. They now have a USD 60 price target on the stock.

12/01/2015 – Merck KGaA was upgraded to “overweight” by analysts at Barclays. They now have a USD 66 price target on the stock.

11/17/2015 – Merck KGaA had its “buy” rating reiterated by analysts at Argus. They now have a USD 65 price target on the stock.

10/30/2015 – Merck KGaA was upgraded to “buy” by analysts at Citigroup.

09/30/2015 – Merck KGaA had its “hold” rating reiterated by analysts at Societe Generale.

06/18/2015 – Merck KGaA had its “underweight” rating reiterated by analysts at Piper Jaffray.

08/27/2014 – Deutsche Bank began new coverage on Merck KGaA giving the company a “hold” rating.

07/08/2014 – Merck KGaA had its “market perform” rating reiterated by analysts at Leerink Swann. They now have a USD 60 price target on the stock.

05/07/2014 – Merck KGaA was downgraded to “equal weight” by analysts at Morgan Stanley.

The share price of Merck KGaA (MKGAY) was up +2.23% during the last day of trading, with a day high of 36.27. 2558 shares were traded during the last session.

The stock’s 50 day moving average is 35.72 and its 200 day moving average is 33.82. The stock’s market capitalization is 47.36B. Merck KGaA has a 52-week low of 26.91 and a 52-week high of 37.16.

Merck KGaA is a Germany-based company engaged in the pharmaceutical industry. The Company diversifies its activities into four business divisions: Merck Serono; Consumer Health; Merck Millipore, and Performance Materials. Within the Merck Serono division, the Company focuses on therapeutic areas and prescription drugs of chemical and biotechnological origin. The Consumer Health division comprises the over-the-counter products for preventive health care and self-treatment of minor ailments. The Merck Serono and Consumer Health divisions form together the Company’s Pharmaceutical business sector. The Merck Millipore division comprises the activities of the Millipore Corporation. The Performance Materials division consists mainly of the Liquid Crystals and Pigments & Cosmetics business units. The Company operates through numerous subsidiaries, including Peer+ BV, AZ Electronic Materials (AZ) and Ormet Circuits Inc., a material supplier for the semiconductor industry.